4don MSN
2 Biotech Giants to Buy in 2026
Both of these players are leaders in their fields.
Stock Connect reshuffle reflects biotech sector's growing role on international stage, though overseas funds remain cautious Mainland Chinese investors can now buy shares in more than a dozen newly ...
Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.
Discover the essentials of stock trading, including different trading types, risk factors, and how to get started on major exchanges like the NYSE and the Nasdaq.
・Puma Biotechnology (PBYI) relies on one product. It has weak fundamentals and has struggled to grow sales. ・PBYI stock has surged 91% over the past year, driven by technical momentum and speculative ...
2025 was a year characterized by both challenges and opportunities for the biotechnology sector. Despite volatility, the segment remained on a high-growth trajectory, driven by several clinical and ...
Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine ...
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk. The success of these companies depends on clinical trial ...
Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has three promising candidates in early development as well as its only ...
Servier’s deal rewrites DAWN’s technical profile, valuing its shares at $21.5 each, which translates to a nearly 70% upside from its previous close. Following this explosive move to the upside, Day ...
Advanced trading has gone mobile. Here are some of NerdWallet’s picks for the best stock trading apps this year. Many, or all, of the products featured on this page are from our advertising partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results